You are eligible to register your Class D medical device with a registrable drug in a secondary role via the abridged evaluation route if it is currently approved by at least one of our independent reference regulatory agencies,
and the chemical or biological component has been evaluated and approved by a competent drug regulatory agency as defined by the World Health Organisation (WHO). This approval must be on the same medical device labelled use that is intended for
the Singapore market.
You need to submit the documents in English.
ASEAN Common Submission Dossier Template (CSDT)
- Executive summary
- Essential Principles Checklist119 KB
- Declaration of Conformity26 KB
- Device description
- Summary of design verification and validation documents:
- Summary of preclinical studies, including the sterilisation validation and shelf life studies (if applicable)
- Summary of Clinical Evaluation Report
- Proposed device labelling
- Risk analysis
- Manufacturer information
- Name and address of the manufacturing and sterilisation sites
- Proof of at least one Quality Management System below:
- ISO 13485
- Conformity to US FDA Quality System Regulations
- Japan MHLW Ordinance 169
- Manufacturing process - flow chart
Fees and turn-around-time
Refer to medical device fees and turn-around-time for more information.
How to register
You will need to register your medical device through the Medical Device Information Communication System (MEDICS).
You will need the following in order to access MEDICS:
If you encounter technical issues, e-mail the HSA helpdesk or call 6776 0168 (from 7.00 am to midnight daily).
Note: You will have to set up a registrant's account in MEDICS in order to complete and submit your product registration application.
Full list of registration guides
If you have a device of another risk class or wish to understand other available registration routes, you may access the full list of registration guides.